Dr. Forsell is a Swedish senior research scientist with more than 10 years of experience in nonclinical drug safety development in therapeutic areas such as diabetes, haemophilia, inflammation and cancer. His knowledge and solid foundation in toxicologic pathology and histology combined with special emphasis in investigative studies gives him a unique skill set valuable to both discovery and non-clinical activities. Specifically, his key expertise includes development of therapeutic antibodies, tissue cross reactivity and biodistribution studies, immunohistochemistry and in situ hybridization techniques, and local tolerance studies. Dr. Forsell has functioned as study director/monitor and project pathologist on numerous non-clinical studies/projects, including managing the design, conduct and interpretation of state-of-the-art GLP studies, as well as preparing reports and documentation for European and American authorities. His experience includes working on inter-disciplinary teams with researchers and contract research organizations in Europe and the USA. Dr. Forsell has also skillfully supervised and trained laboratory staff/students in histology, pathology related techniques and various microscope techniques.